The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nondisruptive mutations of TP53 and overall survival (OS) in advanced non-small-cell lung cancer (NSCLC) patients (p).
Enric Carcereny Costa
No relevant relationships to disclose
Jordi Bertran-Alamillo
No relevant relationships to disclose
Miguel Angel Molina-Vila
No relevant relationships to disclose
Radj Gervais
No relevant relationships to disclose
Bartomeu Massuti
No relevant relationships to disclose
Laura Bonanno
No relevant relationships to disclose
Teresa Moran
No relevant relationships to disclose
Margarita Majem
No relevant relationships to disclose
Enriqueta Felip
No relevant relationships to disclose
M. Rosario Garcia-Campelo
No relevant relationships to disclose
Alain Vergnenegre
No relevant relationships to disclose
Santiago Viteri Ramirez
No relevant relationships to disclose
Amaya Gasco
No relevant relationships to disclose
Luciano Wannesson
No relevant relationships to disclose
Clara Mayo-de las Casas
No relevant relationships to disclose
Laia Pujantell-Pastor
No relevant relationships to disclose
Adolfo G. Favaretto
No relevant relationships to disclose
Niki Karachaliou
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose